Literature DB >> 9822332

Are serum type III procollagen and prolyl hydroxylase useful as noninvasive markers of liver disease in patients with cystic fibrosis?

S Leonardi1, F Giambusso, C Sciuto, S Castiglione, N Castiglione, M La Rosa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9822332     DOI： 10.1097/00005176-199811000-00021

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  4 in total

1.  Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.

Authors:  Tamara N Pereira; Meagan J Walsh; Peter J Lewindon; Grant A Ramm
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

Review 2.  Hepatobiliary complications of cystic fibrosis.

Authors:  Andrew P Feranchak
Journal:  Curr Gastroenterol Rep       Date:  2004-06

3.  Liver fibrosis in patients with chronic liver diseases: are laboratory tests useful to diagnosis?

Authors:  Salvatore Leonardi; Giovanna Vitaliti
Journal:  Hepat Mon       Date:  2011-05       Impact factor: 0.660

Review 4.  Liver disease in cystic fibrosis: an update.

Authors:  Giuseppe Fabio Parisi; Giovanna Di Dio; Chiara Franzonello; Alessia Gennaro; Novella Rotolo; Elena Lionetti; Salvatore Leonardi
Journal:  Hepat Mon       Date:  2013-08-14       Impact factor: 0.660
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.